FDA Approved: VIVJOA — Original Application (Mycovia Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Vivjoa (oteseconazole) from Mycovia Pharmaceuticals for the treatment of recurrent vulvovaginal candidiasis, marking the first approval of otesecon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• VIVJOA (oteseconazole)

Snippet

ORIG AP for VIVJOA (OTESECONAZOLE)